Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
Strategic Initiatives And Analytical Optimism Signal Bright Future In Healthcare Sector
US$611.5
FV
12.5% undervalued intrinsic discount5.62%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
12 days agoauthor updated this narrative
Elevance Health, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$535.17 |
52 Week High | US$555.36 |
52 Week Low | US$431.38 |
Beta | 0.85 |
11 Month Change | 0.92% |
3 Month Change | 0.99% |
1 Year Change | 15.54% |
33 Year Change | 41.04% |
5 Year Change | 86.26% |
Change since IPO | 2,516.97% |
Recent News & Updates
Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Recent updates
Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28Elevance Health acquiring Blue Cross and Blue Shield of Louisiana
Jan 23Elevance Health Offers Great Value
Jan 17At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?
Jan 17Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name
Jan 02Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly
Nov 28Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?
Nov 16Elevance Health to acquire speciality pharmacy from CarepathRx
Nov 09Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price
Nov 02Shareholder Returns
ELV | US Healthcare | US Market | |
---|---|---|---|
7D | 1.5% | 1.6% | -2.8% |
1Y | 15.5% | 10.0% | 16.6% |
Return vs Industry: ELV exceeded the US Healthcare industry which returned 10% over the past year.
Return vs Market: ELV underperformed the US Market which returned 16.6% over the past year.
Price Volatility
ELV volatility | |
---|---|
ELV Average Weekly Movement | 3.7% |
Healthcare Industry Average Movement | 7.0% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 14.5% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ELV has not had significant price volatility in the past 3 months.
Volatility Over Time: ELV's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Elevance Health, Inc. Fundamentals Summary
ELV fundamental statistics | |
---|---|
Market cap | US$124.10b |
Earnings (TTM) | US$6.69b |
Revenue (TTM) | US$171.72b |
18.5x
P/E Ratio0.7x
P/S RatioIs ELV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ELV income statement (TTM) | |
---|---|
Revenue | US$171.72b |
Cost of Revenue | US$123.06b |
Gross Profit | US$48.66b |
Other Expenses | US$41.97b |
Earnings | US$6.69b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 28.85 |
Gross Margin | 28.34% |
Net Profit Margin | 3.90% |
Debt/Equity Ratio | 65.5% |
How did ELV perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield22%
Payout RatioDoes ELV pay a reliable dividends?
See ELV dividend history and benchmarksElevance Health dividend dates | |
---|---|
Ex Dividend Date | Sep 10 2024 |
Dividend Pay Date | Sep 25 2024 |
Days until Ex dividend | 36 days |
Days until Dividend pay date | 51 days |
Does ELV pay a reliable dividends?
See ELV dividend history and benchmarks